Bokemeyer C - Search Results

1

Micro-RNA expression in cisplatin resistant germ cell tumor cell lines.

Port M, Glaesener S, Ruf C, Riecke A, Bokemeyer C, Meineke V, Honecker F, Abend M. Port M, et al. Among authors: bokemeyer c. Mol Cancer. 2011 May 15;10:52. doi: 10.1186/1476-4598-10-52. Mol Cancer. 2011. PMID: 21575166 Free PMC article.

2

Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.

Harstrick A, Schmoll HJ, Wilke H, Köhne-Wömpner CH, Stahl M, Schöber C, Casper J, Bruderek L, Schmoll E, Bokemeyer C, et al. Harstrick A, et al. Among authors: bokemeyer c. J Clin Oncol. 1991 Sep;9(9):1549-55. doi: 10.1200/JCO.1991.9.9.1549. J Clin Oncol. 1991. PMID: 1651992

3

Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.

Bokemeyer C, Schmoll HJ, Natt F, Knoche M, Beyer J, Souchon R. Bokemeyer C, et al. J Cancer Res Clin Oncol. 1994;120(12):754-7. doi: 10.1007/BF01194278. J Cancer Res Clin Oncol. 1994. PMID: 7798304 Clinical Trial.

4

Modulation of cytostatic drugs by nifedipine in two heterotransplanted human testicular-cancer cell lines differing in their sensitivity to standard agents.

Bokemeyer C, Dunn T, Harstrick A, Lerch T, Poliwoda H, Schmoll HJ. Bokemeyer C, et al. Int J Cancer. 1994 Feb 1;56(3):452-6. doi: 10.1002/ijc.2910560328. Int J Cancer. 1994. PMID: 7906255

5

Analysis of a non-ras 21-kDa protein in patients with metastatic testicular germ-cell tumors.

Grundner-Culemann E, Bokemeyer C, Neubauer V, Shalitin C, Schmoll HJ, Poliwoda H, Benter T. Grundner-Culemann E, et al. Among authors: bokemeyer c. J Cancer Res Clin Oncol. 1993;119(11):685-8. doi: 10.1007/BF01215988. J Cancer Res Clin Oncol. 1993. PMID: 8394368

6

Secondary neoplasms following treatment of malignant germ cell tumors.

Bokemeyer C, Schmoll HJ. Bokemeyer C, et al. J Clin Oncol. 1993 Sep;11(9):1703-9. doi: 10.1200/JCO.1993.11.9.1703. J Clin Oncol. 1993. PMID: 8394879

7

Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours.

Bokemeyer C, Kuczyk MA, Dunn T, Serth J, Hartmann K, Jonasson J, Pietsch T, Jonas U, Schmoll HJ. Bokemeyer C, et al. J Cancer Res Clin Oncol. 1996;122(5):301-6. doi: 10.1007/BF01261407. J Cancer Res Clin Oncol. 1996. PMID: 8609154

8

Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis.

Kuczyk MA, Serth J, Bokemeyer C, Jonassen J, Machtens S, Werner M, Jonas U. Kuczyk MA, et al. Among authors: bokemeyer c. Cancer. 1996 Nov 1;78(9):1958-66. doi: 10.1002/(sici)1097-0142(19961101)78:9<1958::aid-cncr17>3.0.co;2-x. Cancer. 1996. PMID: 8909317

9

Amifostine does not alter the antitumor activity of cisplatin in a pre-clinical model of testicular cancer.

Dunn TA, Schmoll HJ, Grünwald V, Bokemeyer C, Casper J. Dunn TA, et al. Among authors: bokemeyer c. Anticancer Drugs. 1996 Sep;7(7):795-9. doi: 10.1097/00001813-199609000-00013. Anticancer Drugs. 1996. PMID: 8949993

10

Pre-clinical activity of taxol in non-seminomatous germ cell tumor cell lines and nude mouse xenografts.

Dunn TA, Grünwald V, Bokemeyer C, Casper J. Dunn TA, et al. Among authors: bokemeyer c. Invest New Drugs. 1997;15(2):91-8. doi: 10.1023/a:1005852521656. Invest New Drugs. 1997. PMID: 9220287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

960 results

Search Page

Filters